Friday, 9 October 2026 | 17:35 - 18:25
Startup Pitching II
Format:In-personLocation:Tokyo Innovation Base (TiB) - 2F - STAGE
BE : Lysantum (Red Cross Belgium)
JP : Corroquium
AT : ABS Biotechnologies
BE : Swiftpharma
DE : AORTEX UG
CH: Synendos Therapeutics
DE : Cynteract
JP : FerroptoCure
8 speakers
Head Business Development - Lysantum HPL
Belgian Red Cross
CEO
Corroquium Co.,Ltd.
CEO
ABS Biotechnologies GmbH
Global Sales & Business Development manager
Swiftpharma bv
CEO
Aortex
CEO
Synendos Therapeutics AG
COO
Cynteract
CEO
FerroptoCure Inc,